Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications
Naslov
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications
Identifikator
/unibl/sci/idNaucniRad:29463
Tip
Pronađite slične unoseAcademic Article
Datum
Pronađite slične unose2021-10
Bibliografski citat
B. Godman, M. Wladysiuk, S. McTaggart, A. Kurdi, E. Allocati, M. Jakovljevic, F. Kalemeera, I. Hoxha, A. Nachtnebel, R. Sauremann, M. Hinteregger, V. Marković Peković, B. Tubić, G. Petrova, K. Tachkov, J. Slaby, R. Nejezchlebova, I. Selke Krulichova, O. Laius, G. Selke, I. Langer, A. Harsanyi, A. Inotai, A. Jakupi, S. Henkuzens, K. Garuoliene, J. Gulbinovic, P. Vella Bonanno, J. Rutkowski, S. Ingeberg, O. Melien, I. Mardare, J. Furst, S. McBride-Stewart, C. Holmes, C. Pontes, C. Zara, M. Turu Pedrola, M. Hoffman, V. Kourafalos, A. Pisana, R. Banzi, S. Campbell, B. Wettermark, Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications, BioMed Research International, Vol. 2021, No. Article ID 99961, pp. 1 - 16, Oct, 2021
Početna stranica
1
Krajnja stranica
16
Je dio
BioMed Research International
2314-6141
Lista autora
Position: 791 (43 views)